Sfoglia per RIVISTA
FUTURE ONCOLOGY (LONDON, ENGLAND)
Collezione AOU Città della Salute di Torino

  

Items : 7

A plain language summary of the PERSEUS study of daratumumab plus bortezomib, lenalidomide, and dexamethasone for treating newly diagnosed multiple myeloma. in Future oncology (London, England) / Future Oncol. 2024;20(38):3043-3063. doi: 10.1080/14796694.2024.2394323. Epub 2024 Sep 17.

2024
AOU Città della Salute di Torino

Sonneveld P; Dimopoulos MA; Boccadoro M; Quach H; Ho PJ; Beksac M; Hulin C; Antonioli E; Leleu X; Mangiacavalli S; Perrot A; Cavo M; Belotti A; Broijl A; Gay F; Mina R; van de Donk NWCJ; Katodritou E; Schjesvold F; Balari AS; Rosiñol L; Delforge M; Roeloffzen W; Silzle T; Vangsted A; Einsele H; Spencer A; Hajek R; Jurczyszyn A; et alii...

Real-world treatment patterns, healthcare resource use and disease burden in patients with multiple myeloma in Europe. in Future oncology (London, England) / Future Oncol. 2023 Oct;19(31):2103-2121. doi: 10.2217/fon-2023-0021. Epub 2023 Sep 14.

2023
AOU Città della Salute di Torino

Haefliger B; Valluri S; Erler-Yates N; Ribbands A; Luke E; Lambert A; Bailey A; Martínez-Lopez J; Gay F;

Italian results of the PRECONNECT study: safety and efficacy of trifluridine/tipiracil in metastatic colorectal cancer. in Future oncology (London, England) / Future Oncol. 2021 Jun;17(18):2315-2324. doi: 10.2217/fon-2020-1278. Epub 2021 Mar 5.

2021
AOU Città della Salute di Torino

Tamburini E; Racca P; Personeni N; Martinelli E; Latiano TP; Giuliani F; Garufi C; Frassineti GL; Costanzo FD; Bartolomeo MD; Bordonaro R; Blasi L; Bergamo F; Banzi MC; Barone CA; Zaniboni A; Tonini G; Besse MG; Spione M; Falcone A;

Isatuximab for relapsed/refractory multiple myeloma: review of key subgroup analyses from the Phase III ICARIA-MM study. in Future oncology (London, England) / Future Oncol. 2021 Dec;17(34):4797-4812. doi: 10.2217/fon-2021-0568. Epub 2021 Sep 15.

2021
AOU Città della Salute di Torino

Richardson PG; Harrison SJ; Bringhen S; Schjesvold F; Yong K; Campana F; Le-Guennec S; Macé S; Dimopoulos MA;

Lenvatinib in differentiated thyroid carcinoma: the Italian experience. in Future oncology (London, England) / Future Oncol. 2019 Aug;15(24s):1-2. doi: 10.2217/fon-2019-0179. Epub 2019 Aug 6.

2019
AOU Città della Salute di Torino

Piovesan A;

Recent advances in clinical studies and the evolving role of subtyping for patients with diffuse large B-cell lymphoma. in Future oncology (London, England) / Future Oncol. 2017 Apr;13(10):859-862. doi: 10.2217/fon-2016-0567. Epub 2017 Feb 10.

2017
AOU Città della Salute di Torino

Nowakowski GS; Vitolo U;

ROBUST: Lenalidomide-R-CHOP versus placebo-R-CHOP in previously untreated ABC-type diffuse large B-cell lymphoma. in Future oncology (London, England) / Future Oncol. 2016 Jul;12(13):1553-63. doi: 10.2217/fon-2016-0130. Epub 2016 Apr 18.

2016
AOU Città della Salute di Torino

Nowakowski GS; Chiappella A; Witzig TE; Spina M; Gascoyne RD; Zhang L; Flament J; Repici J; Vitolo U; Nowakowski GS; Chiappella A; Witzig TE; Spina M; Gascoyne RD; Zhang L; Flament J; Repici J; Vitolo U;